NEW YORK (GenomeWeb) ­– Biocartis announced today that it has submitted its Idylla molecular diagnostics platform to the US Food and Drug Administration for 510(k) clearance, along with a respiratory panel from partner Janssen Diagnostics to detect influenza and respiratory syncytial virus using the Idylla platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.